Datatec to Showcase Strategic Growth at AI & Technology Conference

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Datatec to present at AI & Technology Conference February 19th, showcasing strategic growth through recent acquisitions in managed security services and Eastern European cybersecurity distribution.

Datatec to Showcase Strategic Growth at AI & Technology Conference

Datatec has scheduled a presentation at the AI & Technology Virtual Investor Conference on February 19th, 2026, with Chief Executive Officer Jens Montanana leading the session. The appearance comes as the company continues to build momentum through recent strategic acquisitions aimed at strengthening its technology services portfolio.

The company has recently completed two significant acquisitions designed to expand its capabilities in high-demand market segments. The purchase of Maple Woods Enterprises will bolster Logicalis USA's managed security services division, while a separate acquisition of a Balkans-based cybersecurity distributor extends Datatec's geographical footprint and distribution capabilities in Eastern Europe.

These moves position Datatec to capitalize on growing enterprise demand for integrated security and managed services solutions. The upcoming conference presentation will provide investors with insight into the company's strategic direction and how these acquisitions align with its broader growth objectives in the technology and cybersecurity sectors.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 13

Related Coverage

Benzinga

Mountain Commerce Bancorp Clears Regulatory Hurdles for Home BancShares Merger

Mountain Commerce Bancorp receives Federal Reserve and Arkansas regulatory approvals for merger with Home BancShares, expected to close in early Q2 2026.

HOMBMCBI
Benzinga

Smithfield Foods Surges on Robust Q4 Earnings, Nathan's Famous Deal

Smithfield Foods beat Q4 expectations with 83-cent EPS, announced $450M Nathan's Famous acquisition at $102/share, projecting $1.3-$1.5B FY26 operating profit. Stock surged 4.13%.

SFDNATH
Benzinga

Gilead Bolsters Inflammation Arsenal With $1.675B Ouro Medicines Deal

Gilead acquires Ouro Medicines for $1.675B upfront, targeting inflammation pipeline expansion. Galapagos NV partners to co-develop lead asset OM336.

GILDACLXGLPG
Benzinga

Vertiv Accelerates Capacity Push to Capitalize on AI Data Center Boom

Vertiv expands manufacturing capacity across three facilities and acquires ThermoKey to meet soaring AI data center demand for cooling and power infrastructure.

VRTAIPO
Benzinga

SEALSQ to Acquire Quantum Interconnect Firm Miraex in Strategic Stack Play

SEALSQ signs Letter of Intent to acquire Swiss quantum interconnect firm Miraex, completing its quantum technology stack and supporting space-based quantum infrastructure initiative.

LAESWKEY
Benzinga

VGTEL Eyes Health-Tech Acquisition From 4biddenknowledge in Strategic Bell Rose Deal

VGTEL enters formal discussions with Bell Rose Capital to acquire a pre-revenue health-tech app, with due diligence underway and potential advisory role for Bell Rose's president.

VGTLBELR